QETAR
Quetta Acquisition Corp
No data for this timeframe.
Vol
Inst. Holders1 funds
Inst. Value$70.1K
Inst. Activity1 buys / 0 sells
Recent Activity
Inst.
CITADEL ADVISORS LLC — DOUBLED
43,544 shares ($70.1K)
Inst.
CITADEL ADVISORS LLC — ADD
20,516 shares ($28.7K)
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| CITADEL ADVISORS LLC | $70.1K | DOUBLED |
1 institutional holders with $70.1K total value (43,544 shares) as of 2025-Q1. Top holders: CITADEL. Net buying activity: 1 institutions added/increased vs 0 reduced.
Top Institutional Holders — 2025-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | CITADEL ADVISORS LLC | 43,544 | $70.1K | 100.0% | DOUBLED +112.2% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | DOUBLED | 20,516 | 43,544 | +112.2% | $70.1K | 2025-Q1 |
| CITADEL ADVISORS LLC | ADD | 11,448 | 20,516 | +79.2% | $28.7K | 2024-Q4 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.